These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 28981166)
21. The effects of vasopressin and its analogues on the liver and its disorders in the critically ill. Asfar P; Radermacher P; Calès P; Oberti F Curr Opin Crit Care; 2010 Apr; 16(2):148-52. PubMed ID: 20019608 [TBL] [Abstract][Full Text] [Related]
22. Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1. Boyer TD; Sanyal AJ; Wong F; Frederick RT; Lake JR; O'Leary JG; Ganger D; Jamil K; Pappas SC; Gastroenterology; 2016 Jun; 150(7):1579-1589.e2. PubMed ID: 26896734 [TBL] [Abstract][Full Text] [Related]
23. Terlipressin has stood the test of time: Clinical overview in 2020 and future perspectives. Kulkarni AV; Arab JP; Premkumar M; Benítez C; Tirumalige Ravikumar S; Kumar P; Sharma M; Reddy DN; Simonetto DA; Rao PN Liver Int; 2020 Dec; 40(12):2888-2905. PubMed ID: 33065772 [TBL] [Abstract][Full Text] [Related]
24. Systemic and portal haemodynamic changes following triglycyllysine vasopressin plus nitroglycerin administration in patients with hepatitis B-related cirrhosis. Lin HC; Tsai YT; Lee FY; Chang TT; Wang SS; Lay CS; Lee SD; Lo KJ J Hepatol; 1990 May; 10(3):370-4. PubMed ID: 2114437 [TBL] [Abstract][Full Text] [Related]
25. Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension. Solà E; Lens S; Guevara M; Martín-Llahí M; Fagundes C; Pereira G; Pavesi M; Fernández J; González-Abraldes J; Escorsell A; Mas A; Bosch J; Arroyo V; Ginès P Hepatology; 2010 Nov; 52(5):1783-90. PubMed ID: 20931555 [TBL] [Abstract][Full Text] [Related]
26. Effect of terlipressin infusion therapy on recipient's hepatic and renal functions in living donor liver transplantations: Experience from a tertiary hospital. Karaaslan P; Sevmis S Niger J Clin Pract; 2019 Feb; 22(2):265-269. PubMed ID: 30729953 [TBL] [Abstract][Full Text] [Related]
27. Effects of the vasopressin agonist terlipressin on plasma cAMP and ENaC excretion in the urine in patients with cirrhosis and water retention. Krag A; Pedersen EB; Møller S; Bendtsen F Scand J Clin Lab Invest; 2011 Apr; 71(2):112-6. PubMed ID: 21080762 [TBL] [Abstract][Full Text] [Related]
28. Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study. Mulkay JP; Louis H; Donckier V; Bourgeois N; Adler M; Deviere J; Le Moine O Acta Gastroenterol Belg; 2001; 64(1):15-9. PubMed ID: 11322061 [TBL] [Abstract][Full Text] [Related]
29. Terlipressin-induced hyponatremic encephalopathy in a noncirrhotic patient. Wang YK; Hwang DY; Wang SS; Hwang SJ; Chen LT; Kuo MC Kaohsiung J Med Sci; 2013 Dec; 29(12):691-4. PubMed ID: 24296059 [TBL] [Abstract][Full Text] [Related]
30. Comparison of vasopressin and triglycyl-lysine vasopressin on splanchnic and systemic hemodynamics in dogs. Blei AT; Groszmann RJ; Gusberg R; Conn HO Dig Dis Sci; 1980 Sep; 25(9):688-94. PubMed ID: 7418592 [TBL] [Abstract][Full Text] [Related]
31. Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis. Lee WC; Lin HC; Yang YY; Hou MC; Lee FY; Chang FY; Lee SD Am J Gastroenterol; 2001 Apr; 96(4):1210-6. PubMed ID: 11316172 [TBL] [Abstract][Full Text] [Related]
32. Continuous outpatient terlipressin infusion for hepatorenal syndrome as a bridge to successful liver transplantation. Robertson M; Majumdar A; Garrett K; Rumler G; Gow P; Testro A Hepatology; 2014 Dec; 60(6):2125-6. PubMed ID: 24687396 [No Abstract] [Full Text] [Related]
33. The effect of terlipressin on hepatic hemodynamics in small-for-size livers. Ren Z; Xu Y; Zhu S Hepatogastroenterology; 2012; 59(113):208-11. PubMed ID: 21940362 [TBL] [Abstract][Full Text] [Related]
34. Terlipressin (glypressin) versus somatostatin in the treatment of bleeding esophageal varices--final report of a placebo-controlled, double-blind study. Walker S; Kreichgauer HP; Bode JC Z Gastroenterol; 1996 Oct; 34(10):692-8. PubMed ID: 8921578 [TBL] [Abstract][Full Text] [Related]
35. Effects of terlipressin on systolic pulmonary artery pressure of patients with liver cirrhosis: an echocardiographic assessment. Altintas E; Akkus N; Gen R; Helvaci MR; Sezgin O; Oguz D World J Gastroenterol; 2004 Aug; 10(15):2278-80. PubMed ID: 15259082 [TBL] [Abstract][Full Text] [Related]
36. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Ortega R; Ginès P; Uriz J; Cárdenas A; Calahorra B; De Las Heras D; Guevara M; Bataller R; Jiménez W; Arroyo V; Rodés J Hepatology; 2002 Oct; 36(4 Pt 1):941-8. PubMed ID: 12297842 [TBL] [Abstract][Full Text] [Related]
37. Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome. Krag A; Møller S; Henriksen JH; Holstein-Rathlou NH; Larsen FS; Bendtsen F Hepatology; 2007 Dec; 46(6):1863-71. PubMed ID: 18027874 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of glucagon improves splanchnic hyporesponse to terlipressin in cirrhotic rats with blood retention in the gastric lumen. Yang YY; Lin HC; Huang YT; Hou MC; Lee FY; Chang FY; Lee SD J Hepatol; 2005 May; 42(5):652-8. PubMed ID: 15826713 [TBL] [Abstract][Full Text] [Related]
39. Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study. Cavallin M; Piano S; Romano A; Fasolato S; Frigo AC; Benetti G; Gola E; Morando F; Stanco M; Rosi S; Sticca A; Cillo U; Angeli P Hepatology; 2016 Mar; 63(3):983-92. PubMed ID: 26659927 [TBL] [Abstract][Full Text] [Related]
40. Terlipressin resolves ascites of cirrhotic rats through downregulation of aquaporin 2. Huang YY; Sun JY; Wang JY; Bai CX; He BM J Int Med Res; 2012; 40(5):1735-44. PubMed ID: 23206455 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]